Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06942104 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Imaging of Solid Tumors Using 18F-TRX

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Sep 30, 2026 → Sep 30, 2027
See other at-risk trials from Rahul Aggarwal

Record History

  1. Primary and study completion pushed from Sep 30, 2026 to Sep 30, 2027v5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 31, 2025 to Jul 3, 2025
    • Site details revised
    v4
  3. Start date: May 31, 2025 to Jul 31, 2025v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Rahul Aggarwal
5 trials monitored
See 1 trial at risk
Prostate Cancer
2,546 trials monitored
See 172 trials at risk
Glioma
1,251 trials monitored
See 88 trials at risk
Kidney Cancer
889 trials monitored
See 68 trials at risk
This phase I trial tests the safety and effectiveness of 18F-TRX in detecting tumors (cancer) patients with solid tumors. 18F-TRX is an imaging tracer that is used to visualize tumors using a PET scan. It specifically targets and detects labile (unstable) iron levels within tissues, including tumors. Diagnostic procedures, such as 18F-TRX PET/CT or PET/MRI, may help detect tumors in patients with solid tumors
Trial Details
NCT Number NCT06942104
Lead Sponsor Rahul Aggarwal
Collaborators: United States Department of Defense
Conditions
(from sponsor)		 Solid Tumor, Solid Carcinoma, Castration-Resistant Prostate Carcinoma, Locally Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Malignant Solid Neoplasm, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 +2 more
Related terms Carcinoma, Renal Cell, Clear-cell metastatic renal cell carcinoma, Glioma, Neoplasm Metastasis, Prostatic Neoplasms
Enrollment 56 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov